Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE;ORAL - 10MG
USFDA APPLICATION NUMBER - 18147
DOSAGE - CAPSULE;ORAL - 20MG
USFDA APPLICATION NUMBER - 18147
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Lubricants & Glidants
Granulation
Direct Compression
Disintegrants & Superdisintegrants
Coating Systems & Additives
Thickeners and Stabilizers
Solubilizers
Co-Processed Excipients
Empty Capsules
Controlled & Modified Release
Taste Masking
Emulsifying Agents
Parenteral
Film Formers & Plasticizers
Topical
Coloring Agents
Chewable & Orodispersible Aids
API Stability Enhancers
Rheology Modifiers
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
72
PharmaCompass offers a list of Piroxicam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Piroxicam manufacturer or Piroxicam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Piroxicam manufacturer or Piroxicam supplier.
PharmaCompass also assists you with knowing the Piroxicam API Price utilized in the formulation of products. Piroxicam API Price is not always fixed or binding as the Piroxicam Price is obtained through a variety of data sources. The Piroxicam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Piroxicam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piroxicam, including repackagers and relabelers. The FDA regulates Piroxicam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piroxicam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Piroxicam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Piroxicam supplier is an individual or a company that provides Piroxicam active pharmaceutical ingredient (API) or Piroxicam finished formulations upon request. The Piroxicam suppliers may include Piroxicam API manufacturers, exporters, distributors and traders.
click here to find a list of Piroxicam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Piroxicam DMF (Drug Master File) is a document detailing the whole manufacturing process of Piroxicam active pharmaceutical ingredient (API) in detail. Different forms of Piroxicam DMFs exist exist since differing nations have different regulations, such as Piroxicam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Piroxicam DMF submitted to regulatory agencies in the US is known as a USDMF. Piroxicam USDMF includes data on Piroxicam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Piroxicam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Piroxicam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Piroxicam Drug Master File in Japan (Piroxicam JDMF) empowers Piroxicam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Piroxicam JDMF during the approval evaluation for pharmaceutical products. At the time of Piroxicam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Piroxicam suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Piroxicam Drug Master File in Korea (Piroxicam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Piroxicam. The MFDS reviews the Piroxicam KDMF as part of the drug registration process and uses the information provided in the Piroxicam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Piroxicam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Piroxicam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Piroxicam suppliers with KDMF on PharmaCompass.
A Piroxicam CEP of the European Pharmacopoeia monograph is often referred to as a Piroxicam Certificate of Suitability (COS). The purpose of a Piroxicam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Piroxicam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Piroxicam to their clients by showing that a Piroxicam CEP has been issued for it. The manufacturer submits a Piroxicam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Piroxicam CEP holder for the record. Additionally, the data presented in the Piroxicam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Piroxicam DMF.
A Piroxicam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Piroxicam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Piroxicam suppliers with CEP (COS) on PharmaCompass.
A Piroxicam written confirmation (Piroxicam WC) is an official document issued by a regulatory agency to a Piroxicam manufacturer, verifying that the manufacturing facility of a Piroxicam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Piroxicam APIs or Piroxicam finished pharmaceutical products to another nation, regulatory agencies frequently require a Piroxicam WC (written confirmation) as part of the regulatory process.
click here to find a list of Piroxicam suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Piroxicam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Piroxicam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Piroxicam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Piroxicam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Piroxicam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Piroxicam suppliers with NDC on PharmaCompass.
Piroxicam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piroxicam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piroxicam GMP manufacturer or Piroxicam GMP API supplier for your needs.
A Piroxicam CoA (Certificate of Analysis) is a formal document that attests to Piroxicam's compliance with Piroxicam specifications and serves as a tool for batch-level quality control.
Piroxicam CoA mostly includes findings from lab analyses of a specific batch. For each Piroxicam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piroxicam may be tested according to a variety of international standards, such as European Pharmacopoeia (Piroxicam EP), Piroxicam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piroxicam USP).
